Benzodiazepines should still be first-line treatment for alcohol withdrawal

Publikation: Forskning - peer reviewReview

Vis graf over relationer

In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

OriginalsprogEngelsk
TidsskriftUgeskrift for laeger
Vol/bind179
Tidsskriftsnummer3
Sider (fra-til)2-5
ISSN0041-5782
StatusUdgivet - 2017